Merck invests $110 million to expand production site in China
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels
Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants
The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.
Subscribe To Our Newsletter & Stay Updated